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5INTRODUCTION
Gonadotropin-releasing hormone (GnRH), also called luteinizing hormone-releasing 
hormone (LHRH) system is composed of loosely arranged neuronal elements distributed in 
the human diencephalon. Since the most significant role of GnRH is inducing the release of 
luteinizing hormone (LH) and folliculus stimulating hormone (FSH) via the hypophyseal 
portal circulation, GnRH system represents the final common pathway of a neuronal network 
that integrates multiple external and internal factors to control fertility. The release of GnRH 
into the hypophyseal portal circulation in the median eminence is pulsatile. Cyclic 
fluctuations in the amplitude and frequency of GnRH release, combined with changes in the 
secretory capacity of the pituitary gonadotrophs, are responsible for the generation of the LH 
secretion profile observed over the course of the ovarian cycle. The pulsatile pattern of GnRH 
release is critical for normal ovarian function; in females, the massive increase in GnRH 
release generates the LH surge necessary for ovulation.
Action of estrogen on the LH secretion in human
Among many factors that integrate the activity of the GnRH neuronal system, estrogens 
play the most important role. In the male, and for the greater part of the ovarian cycle in 
females, estrogen exhibit a negative feedback action on LH secretion. However, in the female, 
estrogen, in addition to the negative feedback, also exhibits a positive feedback influence 
upon the activity and output of GnRH neurons to generate the preovulatory LH surge and 
subsequent ovulation (1). Despite the critical effect of estrogen in ovulation, before 2000, the 
scientific community was exploring the mechanism of estrogen action based on the 
assumption that the GnRH neurons themselves do not express estrogen receptors (2). 
Therefore, it was postulated that the action of estrogen upon GnRH neurons was indirect 
involving several estrogen-sensitive neurotransmitter- and neuropeptide-synthesizing systems 
and glial cells that tams-synaptically regulate the activity of the GnRH neurons (1).
Hypothesis: role of interneurons inthe estrogen-modulated GnRH release
It has been recently reported that the GnRH neurons of the rat express estrogen receptor- 
beta (ERP) mRNA, bind 125I-estradiol (3), and possess ER|3 but not ERa immunoreactivity
6(4). Soon after these original reports, the presence of ERp and the lack of ERa within GnRH 
neurons of rats was confirmed in other studies (5). Although both ERa and ERp have been 
successfully localized in the human hypothalamus (6-8), no report indicates the presence of 
ERs in the GnRH neurons of humans. Whether this phenomenon is true or the lack of ERs in 
GnRH neurons in humans is due to technical difficulties remains to be determined. Therefore, 
until solid evidence is provided for the presence of ERs in GnRH neurons in humans, our 
current hypothesis is that the action of estrogen on GnRH neurons is mediated via 
interneurons and glial cells expressing ERs.
Potential neurotransmitter systems mediating the effect of ER on LH release in human
The identification of several neurochemically distinct nerve terminals synapsing on 
GnRH perikarya and dendrites (9) combined with the limited evidence for direct presynaptic 
inputs to GnRH nerve terminals in 
the median eminence (10) in other 
species than humans suggests that 
neurons and/or glial cells may act 
at both sites to regulate GnRH 
neuronal activity and GnRH 
release. An extensive body of 
literature is available with regard 
to the neurochemical regulation of 
LH and GnRH secretion in several 
species (11). Our focus is on 
morphological evidence indicating 
communication potential with 
GnRH neuronal systems in 
primates, particularly in humans.
The afferents of GnRH neurons 
described below containing 
neuropeptides and catecholamines 
arise from multiple locations in the
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Fig. 1. Neurotransmitter systems influencing LH secretion directly 
(1-8) or via hypothalamic GnRH release (9-15). Some interactions 
are hypothetical. Full arrows represent augmentation, dotted arrows 
demonstrate attenuation of the neurotransmitter release. 
Abbreviations: CA, catecholamines; CRH, corticotrophin-releasing 
hormone; EOP, endogenous opiate peptides; GAL, galanin; NPY, 
neuropeptide Y; NT, neurotensin; SP, substance P.
References: 1,(137); 2, (138,139); 3,(94,140); 4,(140); 5,(94); 
6,(95); 7,(141); 8,(116); 9, (161); 10, (160); 11,(142); 12,(137); 
13,(29,30,115); 14,(97); 15,(98-100,143); 16,(52,61,63);
17,(53,54,144); 18,(31); 19,(145).
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7brain. Most of these areas are receptive for estrogen; however, no evidence is available 
indicating that the axon terminals contacting the GnRH neurons arise from cells expressing 
estrogen receptors. Moreover, most of the neuropeptides that contact GnRH neurons either at 
their perikarya, dendrites or at nerve terminals in the median eminence, are also released into 
the hypophysial portal circulatory system. Therefore, they may reach the anterior pituitary and 
directly regulate the secretion of LH. As shown in Figure 1, the neuropeptides and 
catecholamines in the hypothalamus may regulate LH secretion indirectly, by providing 
afferents to GnRH neurons or directly to the pituitary after being released into the 
hypophyseal portal circulation.
Specific Aims
• Comparative analysis of the pattern of GnRH-, CRH-, SP-, NPY-, galanin, 0- 
endorphin-, leu-enkephalin-, and catecholaminergic [tyrosine hydroxylase-IR (TH- 
IR) structures in human hypothalamus
• Computer-aided modelling of the distribution of the perikarya of neurotransmitter 
systems on two- and three-dimensional stereoscopic images (Figs. 2-4).
• Analysis of the peptidergic and catecholaminergic afferents of GnRH neurons based 
on light microscopic double labelling immunocytochemistry (Fig. S).
MATERIALS AND METHODS
Human samples
Human hypothalami were obtained from diagnostic autopsies on women and men with 
different ages in accordance with the regulation of the Ethics Board of Szent Györgyi Albert 
Medical University, Loyola University Chicago and Lake Erie College of Osteopathic 
Medicine (LECOM) (12). The clinical and pathological records of the individuals did not 
contain neurological or neuroendocrinological diseases.
8Immunohistochemistry
Immunocytochemistry for single and double labelling was performed either with the PAP 
or the ABC method in combination with a modified silver intensification technology (13). For 
fluorescent immunohistochemistry, tetramethylrhodamine isothiocyanate (TRITC) was used 
to label GnRH-IR elements and fluorescein isothiocyanate (FITC) labelled secondary 
antibodies to stain the afferents of GnRH-IR neurons. The details of tissue procurement, 
preparation, the immunocytochemical detection and analysis have been described in detail 
previously (12).
Computer-aided three-dimensional modelling of the neurotransmitter systems
The hypothalamic sections were systematically scanned with the aid of a plain-scanner 
(Hewlett-Packard, Palo Alto, CA, USA). The outlines and the immunoreactive elements of 
the sections stained with single-label immunohistochemistry were traced by the CorelTrace 
software 4.0 (Corel Corporation, Ottawa, Ontario, Canada). The neurons and fibers were 
marked on these figures using a Zeiss Axiophot microscope with camera lucida, and Adobe 
Photoshop software, version 5.0. The 3D models were created by the computer-generated 
superimposition of the consecutive sections using VoxBlast NT/9x Version 3.0 Light (Vaytek, 
Image Analysis Facility, University of Iowa, Ames, IA, USA). For those unaccustomed to 
viewing stereoscopic figures by eye, the use of a stereoscopic image viewer is recommended.
Verification of the associations between the neurotransmitter systems
The words: ’’contact, juxtapose, abut” or “innervate” was used throughout the present 
study, although we are aware that the contacts observed at the light microscopic level may not 
always be indicative of classical synapses. Membranes of cells in the brain degrade during the 
relatively long post-mortem period of time (several hours to a day) to the extent that synaptic 
connections with electron microscopic immunocytochemistry cannot be identified. The 
detection of contacts or juxtapositions on 30 pm sections using high magnification (100X) 
with oil immersion were verified on semithin (0.5 pm) plastic-embedded sections. In addition, 
in many cases, these potential synapses were identified with confocal microscopy.
The terminology of the diencephalic structures was adopted from Braak and Braak (14), 
Saper (15) and Silverman (9).
9RESULTS
Distribution of GnRH-IR neurons
(Fig. 2,3)
The GnRH-IR neurons are not concentrated in one brain nucleus, but rather distributed 
widely in a loose network throughout the hypothalamus, as shown in Figs. 2 and 3. The 
number of labeled perikarya varies in the rostrocaudal and mediolateral directions. The 
labeled neurons are located in a 2-mm-wide periventricular zone of the hypothalamus, mainly 
in the preoptic region and in the anterior periventricular nucleus. The number of labeled cells 
gradually decreases in the mediolateral direction, and 16 mm laterally from the ventricular 
ependymal surface no GnRH-IR cell bodies are found. The cell bodies are located mainly in 
the anterior hypothalamus, along the diagonal band of Broca, in the periventricular regions 
and in the tuberal region. The orgánum vasculosum of the lamina terminális (OVLT) contains 
relatively few GnRH-IR 
perikarya. Some GnRH-IR cell 
bodies are also present in the 
paraventricular and supraoptic 
nuclei, while only a few are seen 
in the posterior hypothalamus, 
where the labeled neurons are 
localized around the mamillary 
body. A similar distribution of 
GnRH neurons in the human 
hypothalamus has been reported 
by others (9-12,16-18).
Morphologically, the 
GnRH-IR neurons could be 
classified into two subtypes: 
fusiform and multipolar cells.
The majority of the neurons are 
fusiform with thin cell bodies
Fig. 2. Main subclasses of the gonadotropin-releasing hormone- 
(GnRH)-IR perikarya in the human diencephalon. Colored dots 
represent the cell bodies. The GnRH-IR cells appear to receive 
innervation from the NPY, SP, P-endorphin, leu-enkephalin, CRH, 
galanin, and TH (catecholaminergic) fiber varicosities, except the 
neurons in the septal area (red dots), that do not juxtapose with any 
of these neurotransmitter systems. The most heavily innervated 
GnRH subclasses are located in the infundibulum and median 
eminence (orange dots), followed by the one in the preoptic area 
(green dots). The GnRH-IR neurons in the posterior hypothalamus 
are only occasionally innervated. Color codes: red, septal area; 
blue, lamina terminális; green, preoptic area; orange, infundibulum, 
median eminence; magenta, superior part of tuberal region; cyan, 
posterior hypothalamus. Abbreviations: ac, anterior commissure; 
INF, infundibulum; MB, mamillary body; och, optic chiasm.
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and two processes emanating from opposite poles. The multipolar cells, with triangle-shaped 
or rounded cell bodies, are usually situated in the dorsal portion of the preoptic region.
Many fibers with infrequent branching points and varicosities are present in loose 
bundles within the diagonal band of Broca, seemingly directed towards the OVLT or they run 
above the dorsal surface of the optic chiasm through the medial preoptic area towards the 
tuberal region. The few GnRH-IR fibers of the posterior hypothalamus appear to be 
concentrated around the mamillary body.
Distribution of the NPY-IR neurons
(Fig. 3)
The NPY-IR neurons are scattered throughout the human hypothalamus (Fig.3). 
Numerous perikarya with intense NPY immunoreactivity are found in the septal region, 
rostrally to the lamina terminális, the medial and lateral preoptic and periventricular areas, and 
the tuberal region. Few NPY-IR cell bodies are located in the posterior hypothalamus around 
the mamillary body. In the tuberal region and posterior hypothalamus, NPY-IR perikarya are 
often located periventricularly, whereas, in the medial preoptic area, cells were detected 
mainly in the medial hypothalamus. In general, the number of NPY-IR perikarya en masse 
decreases mediolaterally. The NPY-IR somata are identified as distinct fusiform and 
multipolar neurons. A similar distribution of the NPY neuronal system in the human 
hypothalamus has been reported by Escobar et al. (19).
NPY-IR fibers with many axonal swellings form dense networks along the diagonal band 
of Broca, in the periventricular area, and in the infundibular nucleus. The ventromedial and 
the paraventricular nuclei also contain NPY-IR fibers. Characteristically, the periventricular 
regions and the medial hypothalamus contain more fibers than the lateral hypothalamus. 
However, the lateral part of the preoptic area in the territory of the diagonal band is densely 
populated by NPY-IR fibers.
Juxtapositions between the GnRH-IR and NPY-IR neurons
Superimposition of the maps of GnRH-IR and NPY-IR structures reveal a partial overlap. 
The areas with the highest degree of overlap include the diagonal band of Broca, the 
periventricular areas (preoptic region, anterior periventricular nucleus), and the infundibular
11
LHRH
Fig. 3. Stereoscopic images of the human hypothalamus illustrating the distribution of the luteinizing 
hormone-releasing hormone (LHRH), neuropeptide Y (NPY), substance P (SP) and (3-endorphin (END) 
perikaiya (dots). Stereoscopic images can be seen using U or parallel vision. The eyes are relaxed to look into 
the distance until the pair of the images fuse, and then refocused by the brain. With this technique a 3D 
hypothalamus can be seen on the figure, floating in front of die paper, with the immunolabeled perikarya in it 
at different depth marked by the dots. The optimal viewing distance is approximately 20 inches from the paper 
surface (average reading distance). Stereoscopic magnifier is suggested to readers unfamiliar with U or parallel 
vision. Abbreviations: AC, anterior commissure; INF, infundibulum; MB, mamillary body; och, optic chiasm; 
PH, posterior hypothalamic area; PVN, paraventricular nucleus; S, septal area.
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nucleus. A partial overlap can be observed in the paraventricular nucleus as well. At high 
magnification, NPY-IR varicose fibers are frequently observed to abut on GnRH-IR neurons 
in the preoptic region, periventricular and tuberal areas, but not in the diagonal band of Broca. 
NPY-IR varicosities are found in the immediate vicinity of the GnRH-IR stem dendrites and 
perikarya, which are either fusiform or multipolar in shape. The juxtapositions proved to be 
close axosomatic and axodendritic contacts (Fig. SA and B). The individual GnRH-IR cells 
are often contacted at several sites by the axonal swellings of two or more NPY-IR fibers. In 
some cases, NPY-IR varicose fibers are observed to twine around GnRH-IR neurons (Fig. 
5A). The juxtapositions between GnRH-IR perikarya and NPY-IR fibers are most numerous 
in the infundibular nucleus (64%) followed by the medial preoptic region (36%), and the 
anterior periventricular nucleus (25%).
Distribution of the substance P-IR neurons
(Fig. 3)
The majority (94%) of the SP-IR perikarya are located in the tuberal region (Fig.3). Only 
a few cell bodies are present in the periventricular zone of the preoptic area and in the basal 
part of the posterior hypothalamus. In the tuberal region, the neurons are arranged in several 
subclasses. Most of the perikarya are found in the infundibular region and the median 
eminence. The basal part of the periventricular area and the dorsomedial subdivision of the 
ventromedial nucleus contain an additional cell population. Finally, a well-defined cell group 
is distinguished in the basal perifomical area of the tuberal region. A similar distribution of 
the SP neuronal system in the hypothalamus has been reported by Chawla et al. (20).
Morphologically, the SP-IR neurons could be classified into two subtypes: fusiform or 
multipolar cells. The majority of the cells were fusiform, with oval-shaped cell bodies with a 
process emanating from each of the poles. The multipolar cells, with triangle-shaped or 
rounded cell bodies, are usually situated in the dorsomedial subdivision of the ventromedial 
nucleus.
SP-IR fibers form a loose network throughout the diencephalon. In the septal area, few 
fiber varicosities are present along the diagonal band of Broca and around the anterior 
comissure. In the preoptic area, SP-IR fibers are mainly periventricularly arranged, and a 
delicate fiber network appears around the fornix. In the lateral zone of the preoptic area, SP-
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IR processes are located in the corpus striatum and in the basal part of the diencephalon 
running parallel with the surface of the brain. Most of the fiber varicosities are 
periventricularly arranged in the tuberal region of the diencephalon. A dense network of fibers 
is located around the portal vessels in the infundibulum/pituitary stalk. Few axons are present 
in the paraventricular nucleus. An additional SP-IR fiber population can be distinguished 
running to the infundibulum and the median eminence, passing over the optic tract and 
located laterally on the basal region of the diencephalon. Numerous SP-IR processes are 
located around the fornix in the tuberal region. In the posterior hypothalamus, the axon 
varicosities are found at the base of the 3rd ventricle and in the periventricular area. On the 
lateral part of the posterior hypothalamus, SP-IR fibers are observed at the region of the 
corpus striatum.
Juxtapositions between the GnRH-IR and SP-IR neurons
Superimposing the map of GnRH-IR and SP-IR neural elements reveals that the systems 
overlap in the medial preoptic area, infundibulum, and median eminence. Partial overlap 
occurs in the periventricular zone of the tuberal region and in the paraventricular nucleus. 
Dual-label immunohistochemistry and high magnification microscopic examination reveals 
that SP-IR fiber varicosities abut on GnRH-IR cell bodies in all of these regions (Fig. 5C and 
D). Quantitative analysis of the GnRH-SP juxtapositions shows that the majority of these 
structures (67%) are located in the infundibular area and in the median eminence. In these 
regions, 18% of the GnRH-IR perikarya are heavily innervated (more than three intimate 
contacts), 37% are lightly (one to three intimate contacts) innervated by SP-IR fibers, while 
45% are not closely associated with SP-IR axon terminals. GnRH-SP juxtapositions are also 
present in the medial preoptic area (12%) and in the periventricular zone of the tuberal region 
(21%). Here, the GnRH-IR perikarya are contacted by one to three SP-IR axon varicosities.
The p-endorphin-IR neuronal system 
(Fig. 3)
P-endorphin-IR perikarya form a single, well-circumscribed cell group located in the 
infundibulum/median eminence of the human diencephalon (Fig.3). The cell bodies are often 
found in close proximity to the portal vessels. The P-endorphin-IR neurons are usually
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fusiform in shape with two processes emanating from the opposite poles of the cells. 
However, multipolar cells can be detected in the infundibular nucleus. A similar distribution 
of pro-opiomelanocortin (POMC) expression in the human hypothalamus has been reported 
by Sukhov et al. (21).
(3-endorphin-IR fibers are not arranged into well-defined pathways; rather, they form a 
loose network in the diencephalon mainly populating the periventricular zone and the medial 
hypothalamus. In front of the lamina terminális, (3-endorphin-IR axon varicosities can be 
detected along the diagonal band of Broca and around the anterior commissure. A few fibers 
are found in the basal part of the lamina terminális itself, where they often cross the 
midsagittal line and project contralaterally. In the suprachiasmatic region, most p-endorphin- 
IR processes are located periventricularly in the medial preoptic region and in the dorsomedial 
subdivision of the ventromedial nucleus. Only a few fibers are scattered in the lateral 
hypothalamus. The tuberal region contains delicate fiber network in the infundibulum/median 
eminence, where the p-endorphin-IR fibers are often in close association with the portal 
vessels. The lateral hypothalamic zone of the tuberal area contains few fibers. The most well- 
defined P-endorphin fiber system projects laterally from the infundibulum at the base of the 
diencephalon. In the posterior hypothalamus, P-endorphin-IR axons populate the area around 
the mamillary bodies and the tuberomamillary nucleus. Fibers are also detected in the 
periventricular region of the posterior hypothalamus.
Juxtaposition between the GnRH-IR and P-endorphin-IR neurons
The close associations between the P-endorphin-IR and GnRH-IR elements are mainly 
en passant type of contacts. The majority of these close associations are located in the 
infundibulum/median eminence (68%). Here, GnRH-IR neurons are usually lightly innervated 
(45%) receiving one to three contacts. Heavily innervated (more than three contacts) GnRH- 
IR cells represent a smaller percentage (26%), whereas 29% of the GnRH-IR perikarya do not 
receive any detectable (3-endorphin-IR axon varicosities. A few juxtapositions occur between 
GnRH-IR and (3-endorphin-IR fibers around the wall of the portal vessels. An additional 
subpopulation of p-endorphin-GnRH juxtapositions are observed in the medial preoptic area 
(21%), where the majority of GnRH cell bodies are lightly innervated by P-endorphin-IR 
axons. Finally, a few juxtapositions, with usually one to three contacts/GnRH perikarya, can
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be found at the caudal part of the diagonal band of Broca in close proximity to the lamina 
terminális, and at the basal part of the posterior hypothalamus, laterally to the mamillary 
bodies. Close examination of the P-endorphin-GnRH juxtapositions on semithin sections, 
utilizing oil immersion and high magnification, reveal no cleft between the contacting 
immunoreactive structures (Fig. 5E).
The distribution of Leu-enkephalin-IR neurons 
(Fig-4)
Leu-enkephalin-IR cell bodies are concentrated in three different regions: (i) the vast 
majority of leu-enkephalin-IR perikarya (82%) are observed in the periventricular area of the 
tuberal region; (ii) a few cells are found in the infundibulum in close proximity to the portal 
vessels; and (iii) periventricularly arranged in the medial preoptic area (Fig. 4). The leu- 
enkephalin-IR neurons are mainly fusiform in shape with processes emanating from the 
opposite poles of the cell body. The leu-enkephalin-IR cells are characteristically oriented 
with the axis of the fusiform cell bodies running parallel to the surface of the 3rd ventricle and 
the processes pointing dorsally and ventrally along the axis of the cells.
Leu-enkephalin-IR fibers are detected periventricularly, running along the medial surface 
of the hypothalamus. An additional fiber network projects from the infundibulum towards the 
lateral hypothalamic area. A dense leu-enkephalin-IR axonal network is revealed around the 
fornix and along the lateral part of the anterior commissure. Leu-enkephalin-IR fibers are also 
found in the dorsal part of the lateral hypothalamic area and around the portal vessels. Leu- 
enkephalin-IR fiber varicosities are observed to form fiber baskets in the periventricular area 
of the preoptic and tuberal region. Here, leu-enkephalin-IR axons abut on fusiform neurons, 
which do not show GnRH-immunoreactivity. The fibers are in intimate contact with the 
unidentified neurons and often cover the majority of their surface.
Juxtapositions between the GnRH-IR and leu-enkephalin-IR neurons
Leu-enkephalin-IR and GnRH-IR elements show overlap in the infundibulum/median 
eminence and the medial preoptic area after superimposing the maps of these two systems. 
Partial overlap is detected in the periventricular zone of the tuberal region and at the ventral
16
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Fig. 4. Stereoscopic images illustrating the distribution of the leu-enkephalin (ENK), corticotropin-releasing 
hormone (CRH), galanin (GAL), and tyrosine hydroxylase (TH) (catecholaminergic) perikarya in the human 
hypothalamus (dots). Stereoscopic images can be seen using U or parallel vision. The eyes are relaxed to 
look into the distance until the pair of the images fuse, and then refocused by the brain. With this technique 
a 3D hypothalamus can be seen on the figure, floating in front of the paper, with the immunolabeled 
perikarya in it at different depth marked by the dots. The optimal viewing distance is approximately 20 
inches from the paper surface (average reading distance).
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zone of the posterior hypothalamus, around the mamillary body. Close examination of the 
overlapping areas reveal that leu-enkephalin-IR axons abut GnRH-IR cell bodies and axonal 
processes in these regions (Fig. 5F). The juxtapositions between leu-enkephalin-IR fibers and 
GnRH-IR neurons are detected mainly in the infundibulum and median eminence (78%), 
followed by the medial preoptic area and the periventricular area of the tuberal region (18%). 
A few juxtapositions between the leu-enkephalin and GnRH systems are revealed in other 
areas including the anteroventral periventricular nucleus and the tuberomamillary nucleus 
(4%). No juxtapositions are found rostrally to the lamina terminális.
Distribution of CRH-IR neurons
(Fig. 4)
The vast majority of CRH-IR perikarya (97%) are located in the medial 4 mm zone of the 
human diencephalon (Fig. 4). In front of the lamina terminális, the CRH-IR cells are 
concentrated in the superior part of the diencephalon around the fornix and laterally around 
the anterior commissure. In the preoptic area, the perikarya are periventricularly located 
spreading from the fornix to the optic chiasm. In the tuberal region, the CRH-IR cell bodies 
are concentrated in four areas: (i) the majority of the cells are located in the paraventricular 
nuclei; (ii) in the periventricular region, surrounding the 3rd ventricle from above the fornix to 
the infundibulum; (iii) in the dorsomedial subdivision of the ventromedial nucleus where a 
well-defined group of CRH-IR cells is found; and finally, (iv) a few immunoreactive cells are 
located in the infundibular region. In the posterior hypothalamus, CRH-IR perikarya are 
found in the periventricular region and around the mamillary body. The majority of the CRH- 
IR neurons are fusiform in shape with two to four processes emanating from the opposite 
poles. Numerous, star-shaped multipolar cells are found in the periventricular region.
CRH-IR fibers are organized in several well-defined pathways in the human 
diencephalon. Fibers originating from the infundibulum run laterally, close to the basal 
surface of the hypothalamus. This tract arches over the optic tract dorsally. The CRH-IR 
fibers arising from the paraventricular nucleus (PVN) follow three different directions: (i) a 
well-defined tract run horizontally from the PVN through the substantia innominata of the 
lateral hypothalamus; and (ii) fibers projecting to the base of the diencephalon surround the 
fornix laterally. This tract crosses the infundibular pathway in the tuberal region of the
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hypothalamus, medially to the optic tract, (iii) Axons from the PVN surround the fornix 
medially and project towards the infundibulum/median eminence. An additional set of CRH- 
IR fibers is seen periventricularly. These fibers appear to arise from the periventricularly- 
arranged CRH-IR perikarya. Finally, a delicate fiber network is observed around the anterior 
commissure and the mamillary body. The CRH-IR fibers form a dense network around the 
portal vessels in the tuberal region and are often associated with small blood vessels in the 
PVN and in the periventricular region.
Juxtapositions between CRH-IR and GnRH-IR neurons
Superimposition of the CRH and GnRH maps reveals that these systems overlap mainly 
in the infundibular region, median eminence and medial preoptic area, while partial overlap is 
detected in the periventricular area of the tuberal region and in the basal part of the lateral 
preoptic area (Fig.3 and 4). Characteristically, the CRH-IR fiber varicosities abut fusiform 
GnRH-IR cells forming multiple axosomatic and axodendritic contacts as they pass along the 
neuron (Fig. 5G and H). The majority of the CRH-GnRH juxtapositions (82%) are found in 
the infundibulum and the median eminence followed by the preoptic region (11%), located 
periventricularly in the medial preoptic area and in the anteroventral periventricular nucleus. 
An additional population of juxtapositions is present in the basal part of the lateral 
hypothalamic region at the medial side of the optic tract. No contacts are present between the 
CRH-IR fibers and GnRH-IR cells in the rostral part of the diencephalon, anterior to the 
lamina terminális. Few juxtapositions are observed between CRH-IR and GnRH-IR fibers. In 
some cases, CRH-IR and GnRH-IR axons target the same blood vessel in the periventricular 
area, forming multiple contacts around the vessel wall.
The distribution of galanin-IR neurons 
(Fig. 4)
The majority of the galanin-IR perikarya (96%) are concentrated posteriorly to the lamina 
terminális in different regions: (i) the infundibulum contains densely packed galanin-IR cell 
bodies that are often located around the portal vessels, (ii) Numerous immunoreactive 
perikarya are detected in a narrow zone at the basal surface of the tuberal region. This cell 
population extends from the infundibular nucleus to the optic tract, (iii) Several galanin-IR
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perikarya are detected periventricularly in the chiasmatic and tuberal regions. The 
paraventricular nucleus also contains galanin-IR cell bodies, (iv) In the posterior 
hypothalamus, the galanin-IR neurons are concentrated in the posterior subdivision of the 
periventricular nucleus and in the tuberomamillary nucleus. Few perikarya can be detected in 
the periventricular region of the posterior hypothalamus. In front of the lamina terminális, 
scattered galanin-IR cell bodies are observed along the diagonal band of Broca. Few cells are 
present in the lamina terminális itself. A similar distribution of galanin-IR neurons in the 
human hypothalamus has been reported by Gentleman et al. (22).
The galanin-IR neurons are mainly fusiform in shape with processes emanating from the 
opposite poles of the perikarya. In the periventricular zone, galanin-IR cells are 
characteristically arranged with their longitudinal axis running parallel to the surface of the 3rd 
ventricle. Multipolar galanin-IR cells are present mainly in the infundibulum and in the 
posterior subdivision of the periventricular nucleus.
Galanin-IR fiber varicosities form a dense network in the infundibulum/median eminence. 
Numerous axons can be detected periventricularly in the chiasmatic and tuberal regions. A 
few galanin-IR fibers are present along the diagonal band of Broca, around the anterior 
comissure and fornix, and in the lamina terminális. In the posterior hypothalamus, fibers can 
be seen in the posterior subdivision of the periventricular nucleus, in the tuberomamillary 
nucleus, and in the periventricular region. Sparse galanin-IR axon varicosities are observed in 
the lateral hypothalamus.
Juxtaposition between Galanin-IR and GnRH-IR neurons
Contacts between galanin-IR axon varicosities and GnRH-IR perikarya are present 
mainly in the infundibulum/median eminence of the human hypothalamus. Here, 77% of the 
GnRH-IR neurons are heavily contacted by galanin fibers receiving more than three contacts. 
The rest of the GnRH neurons in this region receive only a few (less then three) contacts per 
neuron. Numerous GnRH-IR cells receive both GnRH and galanin-IR axon varicosities in the 
medial basal hypothalamus. Galanin-GnRH juxtapositions are also present in the medial 
preoptic area and in the periventricular zone of the tuberal region where 24% of the GnRH-IR 
are contacted by galanin-IR nerve processes. A few GnRH-IR perikarya are juxtaposed by 
galanin-IR fibers (one to three contacts) in the posterior subdivision of the periventricular
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Fig. 5. Neurotransmitter systems providing input to the human gonadotropin-releasing hormone (GnRH)- 
immunoreactive (IR) neuronal elements. The position of the neurons is illustrated on schematic sections of the 
human hypothalamus. Double label immunohistochemistry (A-K) demonstrates black, silver impregnated axonal 
varicosities of the actual neurotransmitter systems abutting on brown, GnRH-IR perikarya visualized with DAB 
chromogen. Double label immunofluorescence combined with confocal microscopy at 1 pm virtual sectioning (L) 
provides further evidence of contacts between the intimately associated elements. The neurotransmitter-GnRH 
contacts have been further verified on 1.5 pm thick semithin sections (B). Abbreviations: CRH, corticotrophin- 
releasing hormone; end, B-endorphin; enk, leu-enkephalin; gal, galanin; n, nucleus of the GnRH-IR neuron; NPY, 
neuropeptide-Y; SP, substance P; TH, tyrosine-hydroxylase (representing catecholaminergic neuronal elements).
21
nucleus, in the lamina terminális, and along the diagonal band of Broca. Close examination of 
semithin sections of these intimate associations reveal no gap between the juxtaposing GnRH- 
IR and galanin-IR neural elements (Fig. SI and J).
The distribution of catecholaminergic [tyrosine hydroxylase-IR (TH-IR)] neurons 
(Fig. 4)
In contrast to the GnRH-IR elements, the TH-IR perikarya often form clusters in the 
diencephalon (Fig.4). The majority of the cell bodies are located in the ventral part of the 
preoptic and tuberal areas, whereas few are present in the posterior hypothalamus. The septal 
area contains a small number of immunoreactive cells, concentrated on the medial-dorsal 
region. In the preoptic region, the TH-IR neurons are arranged periventricularly with a few 
cells located at the bottom of the optic recess sitting on the dorsal surface of the optic chiasm. 
The TH-IR cell bodies are densely packed in the paraventricular and supraoptic nuclei. In the 
tuberal region, a large number of cells are present in the median eminence and in the 
periventricular area, whereas the infundibular zone contains sparse TH-IR perikarya. Dorsal 
to the median eminence, a cluster of cell bodies is located between the fomix and the optic 
tract and in the dorsal part of the diencephalon, close to the midline. In the dorsal 
hypothalamus, the cells are arranged periventricularly, with some labelled neurons found 
around the mamillary body. Morphologically, the TH-IR neurons are mainly fusiform, with 
thin cell bodies and two processes emanating from their opposite poles. Smaller numbers of 
multipolar cells are in the paraventricular and supraoptic nuclei. The distribution of 
dopamine-I neurons in the human hypothalamus has been confirmed by Ciliax et al. (23) 
using antisera against the dopamine transporter and are consistent with the location of TH-IR 
cells identified in our studes.
TH-IR fibers are seen as a loose network in the periventricular and infundibular areas. 
Labelled axon varicosities are in the lateral hypothalamus and also in the septal area. 
Interestingly, the TH-IR processes form well-defined terminal fields in the paraventricular 
and supraoptic nuclei.
Juxtapositions between TH-IR and GnRH-IR neurons
Superimposition of the maps of GnRH-IR and TH-IR elements reveals regions of overlap
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in the medial preoptic area and median eminence (Figs.3 and 4). Partial overlap occurs in the 
periventricular zone of the tuberal part of the hypothalamus and in the paraventricular and 
supraoptic nuclei. High magnification examination of the overlapping areas reveals TH-IR 
fibers on GnRH-IR neurons in the medial preoptic and infundibular areas and in the median 
eminence. Here the TH-IR varicose fibers target mainly fusiform GnRH-IR neurons and form 
intimate contact with the cell bodies and the stem dendrites.
The majority of juxtapositions between the GnRH-IR perikarya and TH-IR fibers (78%) 
are located in the infundibular region and median eminence. Here, 12% of the detected 
GnRH-IR cells are heavily (three to five contacts), and 54% are lightly (one to three contacts) 
innervated by TH-IR axon terminals, whereas 34% do not receive TH-IR fibers. The medial 
preoptic area contains fewer juxtapositions (22%) and in the majority of these cases, the 
contacting TH varicosities innervate the GnRH neurons with one to three contacts.
Examination of the juxtapositions with oil-immersion revealed no synaptic cleft between 
the associating TH-GnRH neural elements (Fig. 5K). Also, these intemeuronal connections 
are mostly close axosomatic and axodendritic contacts when examined in fluorescent 
preparations with confocal microscopy (Fig. 5L).
DISCUSSION
The anatomical organization of the GnRH neuronal system in humans is quite different 
from that of rodents. The GnRH-IR perikarya in humans occupy two major regions: 
approximately half of the neurons are located in an anterior region that involves the preoptic- 
septal region and the other half in a posterior region involving the infundibulum (arcuate 
nucleus in rodents). In rodents, the vast majority (over 90%) of GnRH-IR perikarya are 
located rostrally in the diagonal band of Broca, medial septum, and medial preoptic area. 
Although substantial amounts of data indicate that the peptidergic neuronal systems described 
in the present studies innervate the GnRH neurons both in humans and rodents, the 
morphological differences are likely to translate into differences in the pattern of innervation. 
Thus, in the present work we focused on the pattern of juxtapositions between the GnRH 
system and various neurotransmitter sytems in the human hypothalamus. These juxtapositions
23
may be functional synapses and may represent the morphological substrate of GnRH release 
modulated by hypothalamic neurotransmitter systems.
Neurotransmitter systems influencing GnRH release in human - species differences 
The peptidergic and catecholaminergic systems contacting the GnRH neurons convey a 
wide variety of inputs to GnRH neurons that are integrated and translated into an GnRH pulse 
and subsequent LH pulse. Estrogen, via its receptors (ERa and ER($), also uses these neuronal 
systems to fine tune the activity of GnRH neurons. Moreover, estrogen seems to play a “gate­
keeper” function, i.e. when it binds to its receptor present in peptidergic and 
catecholaminergic neurons, the activated ER permits stimulation of GnRH neurons by these 
signals (24). The rank order neuropeptides play in the regulation of GnRH neuronal activity is 
not known. However, in rodents glutamate, GABA, and neurotensin from estrogen-sensitive 
neurons in the anterior ventral periventricular nucleus (AVPV) and norepinephrine from 
estrogen-sensitive brainstem neurons all play an important role in mediating the positive 
feedback action of estrogen necessary for the GnRH and subsequent LH surges resulting in 
ovulation (1,25). The AVPV receives inputs from other brain regions that are critical for the 
LH surge (26), and therefore, integrates and transduces environmental and hormonal signals 
to GnRH neurons. Moreover, the AVPV is sexually dimorphic in rats and neurons in its 
medial division, which are present only in female rats, are coactivated with GnRH neurons at 
the time of the LH surge (27). However, we do not know whether the AVPV even exists in 
humans. In rats, p-endorphin in the arcuate nucleus also plays an important role in mediating 
the effect of estrogen to GnRH neurons whereas the regulatory function of NPY, SP, 
enkephalin, endorphin, CRH, galanin, and catecholamines on estrogen influenced GnRH 
activity appears to be secondary and, in most cases, dependent on the endocrine milieu of the 
animal; for review see Herbison (1). In contrast to rats, only minimal data are available on the 
functions of these neuronal systems in the regulation of GnRH neuronal activity in humans. 
Therefore we will focus our discussion on the peptidergic and catecholaminergic regulation of 
GnRH and LH secretion based on the morphological contacts that these neuronal systems 
make with the GnRH-IR neurons in humans as well as on the information available in the 
literature.
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Regulatory role of hypothalamic neurotransmitter sytems on GnRH and LH release
NPY system
NPY may regulate LH secretion at the level of GnRH neurons or in the anterior pituitary 
gland. It facilitates both GnRH release and gonadotroph responsiveness to GnRH at the time 
of the LH surge in humans (28), primates (29,30) and rats (24,31); for recent review see 
Terasawa et al. (32). In the rat, NPY projections to GnRH neurons arise from two areas: one 
located in the arcuate nucleus and the other in the brainstem (33). Although NPY neurons in 
the arcuate nucleus of the rat express estrogen receptors (31), they do not appear to play a 
pivotal role in the generation of the preovulatory GnRH and subsequent LH surges (34,35) 
and several studies reported that the median eminence is the principal site where NPY 
stimulates GnRH release (34-36). The presence of NPY-IR nerve terminals on GnRH-IR 
perikarya and dendrites in the preoptic area of humans (12), but not in monkeys (37), suggests 
an action of NPY at proximal sites and not at nerve terminals of the human GnRH neuronal 
axis.
Substance P sytem
Substance P is an undecapeptide that modulates gonadal functions in several species 
including human (38-45). Although the exact mechanism of this modulation is not known, 
there is a general consensus that this phenomenon is based on the influence of SP on 
hypophyseal LH release. As for many neuropeptides, SP can alter gonadal function via a 
direct influence on pituitary LH secretion (46-51) and/or by regulation of the hypothalamic 
GnRH system. Subcutaneously administered SP inhibits GnRH-induced LH release via NK1 
receptors (52, 53) and microinjection of the peptide into the medial preoptic area reduces LH 
and FSH levels in the plasma (54). A direct interaction between SP and GnRH systems, as 
first suggested by Tsuruo et al (55) based on electron microscopic observations in rats, may 
take place at the level of GnRH perikarya and dendrites in the medial preoptic area and 
infundibular stalk/median eminence regions in humans (46) and be the morphological 
substrate for the SP-controlled regulation of gonadal functions in humans.
0-endorphin system
Although previous studies described P-endorphin-IR elements in the hypothalamus of
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numerous species including rat and human (47-49), only one study provided a high resolution 
mapping of the P-endorphin-IR system in the entire human hypothalamus (50). There is a 
general agreement that p-endorphin-IR perikarya are primarily found in the 
infundibulum/median eminence and p-endorphin-IR axon varicosities in the periventricular 
zone and medial hypothalamus. The relative small number of perikarya in contrast to the large 
number of P-endorphin-IR fibers suggests that either the sensitivity of detection in humans is 
not sufficient to visualize the entire P-endorphin-IR system or P-endorphin-IR processes may 
have extrahypothalamic origin. In rodents, the detection of p-endorphin-IR perikarya requires 
the use of colchicine, a drug that blocks axoplasmic transport and thereby accumulates the 
neuropeptide in the perikarya. As far as other locations of P-endorphin-IR perikarya are 
concerned, in rodents, neurons in the nucleus of the solitary tract/area postrema region also 
express P-endorphin (51).
Physical dependence to opiate drugs in humans is frequently associated with disruption of 
hypothalamo-pituitary-gonadal functions. Since P-endorphin, an endogenous opioid peptide, 
interacts with the same receptors (p ipioid receptors) that are stimulated by opiate alkaloids, 
such as morphine, it is generally believed that p-endorphin is one of the major factors 
regulating gonadal homeostasis. Indeed, several studies revealed that P-endorphin is involved 
in the control of gonadal functions by influencing LH release of the pituitary gland in several 
species including humans (56).
Since neither basal nor GnRH-stimulated LH release in rat is blocked by endogenous 
opioid peptides when tested on hemipituitary tissue samples in vitro (57-59), and GnRH 
receptor antagonists block the naloxone-induced LH release (60), there is a general consensus 
that P-endorphin regulates LH secretion via GnRH release (59,61-64). P-endorphin nerve 
fibers communicate with GnRH neurons in rodents (65), monkey (66) and humans (50). p* 
endorphin has long been implicated in mediating the negative feedback action of estrogen on 
GnRH neurons since, in rats, a subpopulation of P-endorphin cells expresses estrogen 
receptors (67). However, to date, no p, 8 or k opioid receptor mRNAs have been found within 
GnRH neurons. Thus, P-endorphin does not appear to play a primary role in mediating the 
negative feedback action of estrogen on GnRH secretion. Rather, the current concept 
proposed by Herbison (1) is that P-endorphin neurons form a component of the GnRH 
network that maintains a continuous inhibitory tone within the network and that this may be
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involved in determining the dynamics of individual GnRH pulses (68). In contrast, p- 
endorphin is implicated in mediating stimulatory effects of estrogen on GnRH neurons 
(31,69).
There is disagreement at present over the participation of other neurotransmitter systems 
in the P-endorphin-controlled LH release. However, the close contacts between the p- 
endorphin-IR and GnRH-IR systems in humans (50), monkeys (66) and rodents (48) indicate 
that P-endorphin may directly regulate hypothalamic GnRH release.
In addition to contacts to GnRH-IR and other types of neurons in the hypothalamus, 
several P-endorphin-IR axon varicosities apposed portal vessels in the infundibulum and the 
median eminence (50). These observations suggest that P-endorphin in primates may be 
released into the portal blood stream and regulate the function of the anterior pituitary gland.
Leu-enkephalin system
Leu-enkephalin, another opioid peptide, may also have dual action on LH secretion acting 
at the level of the hypothalamus and on the anterior pituitary gland (Fig. 1). Although there 
are plenty of publications reporting the distribution of leu-enkephalin in the rodent brain (JO- 
73), only one study has reported the distribution of leu-enkephalin in the human 
hypothalamus (74). In the human hypothalamus, the majority of leu-enkephalin-IR perikarya 
are present in the periventricular area of the hypothalamus and the infundibulum. In contrast 
to these findings, the leu-enkephalin-IR fibers form a delicate network throughout the entire 
hypothalamus without any well-distinguishable pathways. Although the periventricularly 
located leu-enkephalin fibers seem to originate from the periventricularly located leu- 
enkephalin-IR cell bodies, most leu-enkephalin-IR axon varicosities appear to be of 
extrahypothalamic origin.
As with P-endorphin, there is a general consensus that leu-enkephalin influences pituitary 
LH secretion via regulating hypothalamic GnRH release. However, the reported effects and 
sites of action of opiate agonists and antagonists on reproduction is controversial. Opioid 
agonists were reported to decrease the GnRH-controlled release of LH from the anterior 
pituitary gland in several species, including rats, monkeys (75) and humans (76,77). The 
release of GnRH from medial basal hypothalamic fragments can be inhibited by 
submicromolar concentrations of leu-enkephalin (78). Conversely, opiate antagonists
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stimulate LH secretion in rats (57,79,80), sheep (81), and primates (82-84), including humans 
(76,77,85,86).
Although several studies reported other neurotransmitter systems may be involved in the 
leu-enkephalin-controlled GnRH secretion (87-90), direct innervation of GnRH neurons by 
the leu-enkephalin system has also been suggested (75). Our studies in humans revealed that 
the majority of the leu-enkephalin-GnRH juxtapositions (78%) were detected in the 
infundibulum, whereas in the medial preoptic area only a few GnRH cells were in close 
association with leu-enkephalin-IR axonal varicosities. These data indicate that modulation of 
GnRH by leu-enkephalin may be localized to the infundibular area and the median eminence. 
GnRH-IR nerve terminals in the median eminence receive presynaptic contacts from 
tuberoinfundibular dopaminergic (TIDA) neurons in the newt (91) and sheep (10). The TIDA 
neurons of hyperprolactinemic female rats (pregnant, lactating, aged or pharmacologically 
hyperprolactinemic) co-express leu-enkephalin (72,73). Therefore, it is possible that via these 
putative presynaptic connections between TIDA nerve terminals and GnRH-IR nerve 
terminals, enkephalin, colocalized with dopamine, may regulate GnRH release in the median 
eminence of the rat as well. The juxtapositions between leu-enkephalin and GnRH processes 
in the human infundibulum reported in the present studies and the presence of opioid 
receptors in the infundibulum and median eminence (92) suggest that a similar mechanism 
may also exist in the human. It may be speculated that, during lactation, leu-enkephalin, 
colocalized with dopamine, the physiological prolactin release-inhibiting factor, may either 
increase prolactin synthesis/secretion from the anterior pituitary gland and counterbalance the 
inhibitory action of dopamine and/or modulate the pulsatile pattern of GnRH release into the 
hypophysial portal circulation.
CRH system
Gonadal functions are suppressed by prolonged stress. Although it is generally believed 
that this phenomenon involves the inhibition of LH release by catecholamines, there is 
growing evidence that CRH plays a pivotal role in the stress-related suppression of 
reproductive functions (93). Although CRH directly influences LH release in rat and human 
pituitary cells in vitro (94,95), there is a general consensus that the effect of CRH on gonadal 
functions is based on the CRH-mediated inhibition of LH secretion via suppression of
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hypothalamic GnRH release. Administration of CRH into the 3rd ventricle blocks the 
preovulatory GnRH-mediated LH surge in ewe (96). CRH infusion into the medial preoptic 
area or into the median eminence of the rat inhibits LH secretion through altering GnRH 
release (97-99). Moreover, CRH directly suppresses GnRH transcription in cell culture (100).
Although several studies indicated that endogenous opiate peptides mediate the 
regulation of gonadal functions by CRH (94,101,102), there is growing evidence that CRH 
may directly regulate GnRH release in the hypothalamus. Indeed, synaptic connections have 
been found between CRH- and GnRH-IR elements in the rat medial preoptic area (103). The 
infundibular region and the median eminence, two major locations of GnRH perikarya and 
fibers in humans, are targeted by CRH-IR fibers from the paraventricular nucleus and from 
periventricularly arranged CRH-IR perikarya. In these locations CRH-IR fibers are 
juxtaposed to GnRH-IR neurons (104) and may represent CRH-controlled GnRH release in 
the human hypothalamus.
Galanin system
Galanin, a 29 amino acid peptide (1,105) is widely distributed in the central and 
peripheral nervous systems. Centrally, galanin impairs cognitive performance, stimulates 
feeding behaviour, and inhibits spinal excitability (106-108). In the neuroendocrine system, 
galanin induces the release of prolactin (109-112) and growth hormone (113,114). Recent 
studies reveal that galanin also modulates gonadal functions via the hypothalamo- 
hypophyseal axis by regulating pituitary LH release (115).
Galanin may regulate LH secretion at the level of the pituitary (116), via regulation of 
GnRH release and/or in a paracrine fashion, since galanin is synthesized locally in the anterior 
pituitary (117,118). Galanin levels are higher in the hypophyseal portal blood than in the 
peripheral circulation, and galanin release into the hypophyseal portal circulation follows a 
pulsatile fashion (115). These observations suggest that galanin also functions as a 
hypothalamic, hypophysiotropic hormone. Tract-tracing studies in rats confirmed these 
functional observations by demonstrating retrogradely-labelled neurons in the arcuate and 
paraventricular nuclei from the median eminence (119)..
Galanin (120) and its receptors (121,122) are found in large concentrations in the preoptic 
area of the hypothalamus and galanin is co-expressed in a subpopulation of GnRH neurons of
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the rat (123). The degree of co-expression is estrogen-dependent and sexually dimorphic 
(123,124). The stimulatory action of estrogen on galanin expression in rats is mediated via 
ERP (125), also present in a subpopulation of GnRH-IR neurons (3,4). However, galanin has 
been shown to dramatically increase GnRH release from nerve terminals in the median 
eminence (115), suggesting that this is the site of action of galanin. However, the fact that the 
principal receptor expressed in GnRH neurons is the Gal-Rl (126) makes stimulation of 
GnRH release by galanin difficult to explain, since the Gal-Rl signaling pathways are 
inhibitory (127). As suggested by Steiner’s group (156), it is possible that when GnRH 
neuronal activity is low, galanin, co-released with GnRH, blocks subsequent small amounts of 
GnRH released, however, when GnRH neuronal activity is elevated, galanin cannot suppress 
such large bulk release and creates a larger potential difference at the GnRH terminal. Via this 
mechanism, galanin may sharpen the pulsatile pattern of GnRH release into the hypophysial 
portal circulation necessary for induction of an LH surge and subsequent ovulation.
In addition to an autocrine action of galanin in GnRH neuronal activity, the observations 
that galanin-IR fiber varicosities abut GnRH-IR perikarya in the preoptic area of the human 
(105) and rat (123) brain suggest that galanin may control hypothalamic GnRH activity via 
synaptic communications. Although numerous data suggest that galanin is one of the major 
modulators of reproductive functions in the rat, it has not been shown to stimulate basal or 
GnRH-stimulated LH secretion in the pituitary of humans (128-130). However, the well- 
defined juxtapositions between galanin-IR and GnRH-IR neural elements in the human 
diencephalon (120) suggest galanin-controlled GnRH release. The recent discovery of galanin 
receptors and receptor subtype-specific agonists and antagonists should provide an impetus 
for further research aimed at dissecting out the function of galanin in central regulation of 
reproduction (127).
Catecholaminergic system
The connections between GnRH-IR and TH-IR neurons shown in this study could 
represent dopamine, epinephrine and/or norepinephrine, since TH is the first and rate-limiting 
enzyme for catecholamine synthesis. Although the morphology and distribution of GnRH 
(9,12,16-18,131) and catecholaminergic neuronal systems (132-135) have been mapped in 
humans, the structural relationship between these systems has not been studied. The role of all 
three of these neurotransmitters in the control of GnRH neuronal activity is controversial and
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probably species-dependent (1, 165). It appears that stimulatory or inhibitory roles in LH 
secretion depend on the endocrine milieu and may change during sexual maturation. On the 
basis of recent molecular and neuroanatomical data, it is proposed that estrogen influences 
brainstem noradrenergic neurones specifically within the nucleus tractus solitarius (A2) to 
facilitate synaptic transmission within the GnRH network. In this manner, norepinephrine is 
likely to play a role in increasing GnRH mRNA expression and secretion necessary for 
ovulation. In addition to conveying the effects of estrogen, the A2 norepinephrinergic system 
integrates several visceral and peripheral inputs and, therefore, is well positioned to modulate 
the activity of GnRH and other neuropeptides/neurotransmitters interacting with GnRH 
neurons in response to homeostatic and environmental stimuli. Currently, norepinephrine is 
considered as a permissive factor promoting high output states of the GnRH neuronal network 
(136). This notion is based on the observations that adrenergic receptor antagonists block the 
actions of various neuropeptides/neurotransmitters on LH secretion (31). Although these 
findings originally were explained as a serial arrangement among the 
neuropeptides/neurotransmitters, norepinephrine and the GnRH neurones, it is now 
considered (1,136) that there is a parallel relationship between the actions of 
neuropeptides/neurotransmitters and norepinephrine. With removal of the permissive effect of 
norepinephrine within the GnRH network, the effect of neuropeptides/neurotransmitters 
contacting GnRH neurons becomes silent. Thus, the demonstration of TH-IR fibers contacting 
GnRH-IR neurons in the human hypothalamus suggests an evolutionarily conserved role for 
the norepinephrine system.
SUMMARY
• The present studies provided high resolution, three dimensional maps of NPY, SP, P- 
endorphin, leu-enkephalin, CRH, galanin and catecholaminergic neurotransmitter systems 
in the human hypothalamus.
• These neurotransmitter systems form intimate associations with the hypothalamic GnRH- 
IR neurons in humans mainly in the medial preoptic area and in the median eminence.
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• Since close examination of these juxtapositions using semithin sections or confocal 
microscopy revealed no gaps between the contacting elements, these associations may be 
functional synapses, and may represent the modulation of GnRH secretion by various 
neurotransmitter sytems in humans.
• Although there are no data from the human brain as to whether these peptidergic and 
catecholaminergic neurons or the GnRH neurons express estrogen receptors, data from 
rodents and primates strongly suggest that the modulatory actions of estrogen are, indeed, 
mediated via these neurotransmitters/neuromodulators.
• In a series of studies we conducted in the human hypothalamus, we noticed that a subset 
of GnRH-IR neurons in front of the lamina terminális did not have contacts from any of 
the neuropeptides (NPY, SP, leu-enkephalin, (B-endorphin, CRH, galanin) or 
catecholaminergic systems suggesting that they form a subpopulation(s) that may have an 
entirely different regulatory mechanism and function than the remaining GnRH-IR 
perikarya.
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